• 1
    Platts-Mills TA, Rosenwasser LJ. Chronic sinusitis consensus and the way forward. J Allergy Clin Immunol 2004;114:13591361.
  • 2
    Inamura K, Ohta N, Fukase S, Kasajima N, Aoyagi M. The effects of erythromycin on human peripheral neutrophil apoptosis. Rhinology 2000;38:124129.
  • 3
    Cervin A. The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol 2001;121:8392.
  • 4
    Dejima K, Hama T, Miyazaki M, Yasuda S, Fukushima K, Oshima A et al. A clinical study of endoscopic sinus surgery for sinusitis in patients with bronchial asthma. Int Arch Allergy Immunol 2005;138:97104.
  • 5
    Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffey TA, Tarara JE et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: is the histopathology similar to asthma? J Allergy Clin Immunol 2003;112:877882.
  • 6
    Dhong HJ, Kim HY, Cho DY. Histopathologic characteristics of chronic sinusitis with bronchial asthma. Acta Otolaryngol 2005;125:169176.
  • 7
    Kuhn FA, Swain R Jr. Allergic fungal sinusitis: diagnosis and treatment. Curr Opin Otolaryngol Head Neck Surg 2003;11:15.
  • 8
    Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005;60:7179.
  • 9
    Settipane GA, Chafee FH. Nasal polyps in asthma and rhinitis. A review of 6037 patients. J Allergy Clin Immunol 1977;59:1721.
  • 10
    Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc 1996;17:231236.
  • 11
    Romanet-Manent S, Charpin D, Magnan A, Lanteaume A, Vervloet D. Allergic vs nonallergic asthma: what makes the difference? Allergy 2002;57:607613.
  • 12
    Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003;21:483513.
  • 13
    Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K et al. CDld-restricted and TCR-mediated activation of Valpha14 NKT cells by glycosylceramides. Science 1997;278:16261629.
  • 14
    Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003;9:582588.
  • 15
    Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M et al. CD4+ invariant T-cell-receptor + naturel killer T cells in bronchial asthma. N Engl J Med 2006;354:11171129.
  • 16
    Meltzer EO, Orgel HA, Backhaus JW, Busse WW, Druce HM, Metzger WJ et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92:812823.
  • 17
    Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114:155212.
  • 18
    Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225244.
  • 19
    Okuda M, Okamoto M, Nomura Y, Saito Y. Clinical study on beclomethasone dipropionate powder preparation (TL-102) in perennial nasal allergy. Rhinology 1986;24:113123.
  • 20
    Metelitsa LS, Wu HW, Wang H, Yang Y, Warsi Z, Asgharzadeh S et al. Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2. J Exp Med 2004;199:12131221.
  • 21
    Bonecchi R, Bianchi G, Bordignon PP, D’Ambrosio D, Lang R, Borsatti A et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187:129134.
  • 22
    Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997;99:S781S786.
  • 23
    Meyer EH, Goya S, Akbari O, Berry GJ, Savage PB, Kronenberg M et al. Glycolipid activation of invariant T cell receptor+ NKT cells is sufficient to induce airway hyperreactivity independent of conventional CD4+T cells. Proc Natl Acad Sci U S A 2006;103:27822787.